Christopher Rajkumar

ORCID: 0000-0002-0086-1113
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Pain Management and Treatment
  • Cardiovascular Health and Disease Prevention
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Function and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Disease and Adiposity
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Effects of Exercise
  • Cardiovascular and exercise physiology
  • Cerebrovascular and Carotid Artery Diseases
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac electrophysiology and arrhythmias
  • Cardiac, Anesthesia and Surgical Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Health and Mental Health
  • Mobile Health and mHealth Applications
  • Peripheral Artery Disease Management
  • Cardiac Structural Anomalies and Repair
  • Heart Rate Variability and Autonomic Control

Hammersmith Hospital
2003-2025

Imperial College London
2004-2025

Lung Institute
2020-2025

Imperial College Healthcare NHS Trust
2017-2025

National Health Service
2024

Xavier Institute of Management and Entrepreneurship
2023

St. Marianna University School of Medicine
2022

Mayo Clinic in Arizona
2020

St Mary's Hospital
2019

St. Mary's Hospital
2019

Most people who begin statins abandon them, most commonly because of side effects.The purpose this study was to assess daily symptom scores on statin, placebo, and no treatment in participants had abandoned statins.Participants received 12 1-month medication bottles, 4 containing atorvastatin 20 mg, empty. We measured intensity for each using an app (scale 1-100). also the "nocebo" ratio: ratio symptoms induced by taking statin that placebo.A total 60 were randomized 49 completed 12-month...

10.1016/j.jacc.2021.07.022 article EN cc-by Journal of the American College of Cardiology 2021-09-01

Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving antianginal medication remains unknown. We conducted double-blind, randomized, placebo-controlled trial with Patients stopped all medications and underwent 2-week symptom assessment phase before randomization. were then randomly assigned 1:1 ratio undergo or followed for 12 weeks. The primary end...

10.1056/nejmoa2310610 article EN New England Journal of Medicine 2023-11-11

BackgroundThe coronary sinus reducer (CSR) is proposed to reduce angina in patients with stable artery disease by improving myocardial perfusion. We aimed measure its efficacy, compared placebo, on ischaemia reduction and symptom improvement.MethodsORBITA-COSMIC was a double-blind, randomised, placebo-controlled trial conducted at six UK hospitals. Patients aged 18 years or older angina, disease, ischaemia, no further options for treatment were eligible. All completed quantitative...

10.1016/s0140-6736(24)00256-3 article EN cc-by The Lancet 2024-04-01

In this study, a systematic analysis was conducted of phasic intracoronary pressure and flow velocity in patients with severe aortic stenosis (AS) coronary artery disease, undergoing transcatheter valve replacement (TAVR), to determine how AS affects: 1) flow; 2) hyperemic 3) the most common clinically used indices severity, instantaneous wave-free ratio fractional reserve. A significant proportion have concomitant disease. The effect on pressure, flow, established invasive clinical severity...

10.1016/j.jcin.2018.07.019 article EN cc-by КАРДИОЛОГИЯ УЗБЕКИСТАНА 2018-08-25
Florentina Simader Christopher Rajkumar Michael Foley Fiyyaz Ahmed‐Jushuf Shayna Chotai and 90 more Nina Bual A. M. Khokhär Aisha Gohar Ioannis Lampadakis Sashiananthan Ganesananthan Rachel H. Pathimagaraj Alexandra N. Nowbar John R. Davies Tom R. Keeble Peter O’Kane Peter Haworth Helen Routledge Tushar Kotecha James C. Spratt Rupert Williams Sukhjinder Nijjer Sayan Sen Nick Curzen Manas Sinha James P. Howard Graham Cole Frank E. Harrell Dárrel P. Francis Matthew Shun‐Shin Rasha Al‐Lamee Christopher Rajkumar Michael J. Foley Fiyyaz Ahmed‐Jushuf Florentina Simader Sashiananthan Ganesananthan Danqi Wang Muhammad Mohsin Rachel Pathimagaraj Krzysztof Macierzanka Ricardo Petraco Ramzi Khamis Graham Cole James P. Howard Jamil Mayet Dárrel P. Francis Arif Kokhar Aisha Gohar Ioannis Lampadakis Henry Seligman Amit Kaura Sukhjinder Nijjer Sayan Sen Ramrakha Punit Raffi Kaprielian Iqbal Malik Masood Khan Amarjit Sethi Rodney A. Foale Thomas R. Keeble Kare Tang John R. Davies Reto Gamma Gerald J. Clesham Jason Dungu Alamgir Kabir Shah Mohd Nazri Peter O’Kane Jonathan Hinton Jehangir Din Alexandra N. Nowbar Tushar Kotecha Peter Haworth James C. Spratt Rupert Williams Claudia Cosgrove Pitt Lim Helen Routledge Lal Hussain Mughal Jasper Trevelyan Manas Sinha Nick Curzen James S. Wilkinson Rohit Sirohi Alison Calver John Rawlins Richard J. Jabbour Neil Ruparelia Joban Sehmi Tim Kinnaird Fairoz Abdul Vasileios Panoulas David Collier George F. Thornton Sohaib Afzal Rasha Al‐Lamee

10.1016/j.jacc.2024.04.016 article EN Journal of the American College of Cardiology 2024-05-15

Dobutamine stress echocardiography is widely used to test for ischemia in patients with stable coronary artery disease. In this analysis, we studied the ability of prerandomization score predict placebo-controlled efficacy percutaneous intervention (PCI) within ORBITA trial (Objective Randomised Blinded Investigation With Optimal Medical Therapy Angioplasty Stable Angina).One hundred eighty-three underwent dobutamine before randomization. The broadly number segments abnormal at peak stress,...

10.1161/circulationaha.119.042918 article EN cc-by Circulation 2019-11-11

Cardiac perforations caused by pacemaker or implantable cardioverter-defibrillator (ICD) leads are uncommon but potentially fatal events. The optimal approach to such cases is unclear. aim of this study was identify the imaging modality and management strategy for cardiac perforation.All patients presenting a single institution with perforation >24 h since implant between 2011 2015 were identified retrospectively. Assessment diagnostic performance pre-extraction chest radiography,...

10.1093/europace/euw074 article EN EP Europace 2016-06-27

Oxygen-pulse morphology and gas exchange analysis measured during cardiopulmonary exercise testing (CPET) has been associated with myocardial ischaemia. The aim of this was to examine the relationship between CPET parameters, ischaemia anginal symptoms in patients chronic coronary syndrome determine ability these parameters predict placebo-controlled response percutaneous intervention (PCI).

10.1093/eurheartj/ehac260 article EN European Heart Journal 2022-05-26

Although state-of-the-art therapy for left main disease (LMD) has been demonstrated to improve overall cardiovascular outcomes, it remains unclear whether differences in strategy and outcomes Japanese non-Japanese patients can be observed a contemporary treatment.

10.1536/ihj.24-375 article EN International Heart Journal 2025-03-30

Objective International guidelines recommend the use of dual antiplatelet therapy (DAPT) after transcatheter aortic valve implantation (TAVI). The recommended duration DAPT varies between guidelines. In this two-part study, we (1) performed a structured survey 45 TAVI centres from around world to determine if there is consensus among clinicians regarding TAVI; and then (2) systematic review all suitable studies (randomised controlled trials (RCTs) registries) aspirin monotherapy can be used...

10.1136/openhrt-2017-000748 article EN cc-by-nc Open Heart 2018-01-01

Patients with severe aortic stenosis (AS) often have coronary artery disease. Both the valve and disease influence blood flow to myocardium its ability respond stress; leading exertional symptoms. In this study, we aim quantify effect of AS on microcirculation determine if is influenced by any concomitant We then compare stenoses microcirculation.Group 1: 55 patients intermediate treated transcatheter implantation (TAVI) were included. Group 2: 85 no percutaneous intervention Coronary...

10.1161/circinterventions.119.008263 article EN cc-by Circulation Cardiovascular Interventions 2019-11-22

Despite guideline-based recommendation of the interchangeable use instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) to guide revascularization decision-making, iFR/FFR could demonstrate different physiological or clinical outcomes in some specific patient lesion subsets. Therefore, we sought investigate impact difference between iFR FFR-guided decision-making on patients with left main disease (LMD). In this international multicenter registry LMD interrogation, identified...

10.1007/s12928-024-00989-4 article EN cc-by Cardiovascular Intervention and Therapeutics 2024-04-20

Abstract There have been no studies comparing clinical outcomes of physiology-guided revascularization in patients with unprotected left main coronary disease (ULMD) between percutaneous intervention (PCI) vs. artery bypass grafting (CABG). The aim this study was to assess the long-term PCI and CABG physiologically significant ULMD. From an international multicenter registry ULMD interrogated instantaneous wave-free ratio (iFR), we analyzed data from 151 (85 66 CABG) who underwent according...

10.1007/s12928-023-00932-z article EN cc-by Cardiovascular Intervention and Therapeutics 2023-04-05

Background: The majority of randomized controlled trials revascularization decision-making excludes left main coronary artery disease (LMD). Therefore, contemporary clinical outcomes patients with stable and LMD proven ischemia remain poorly understood. aim this study was to assess the long-term physiologically significant according treatment strategies versus deferral. Methods: In international multicenter registry interrogated instantaneous wave-free ratio, (instantaneous ratio ≤0.89) were...

10.1161/circinterventions.122.012700 article EN cc-by-nc-nd Circulation Cardiovascular Interventions 2023-06-01
Coming Soon ...